Resources: Affiliate News
FDA approves remdesivir as first coronavirus drug
The FDA on Thursday approved Gilead's coronavirus drug remdesivir — making it the only Covid-19 treatment to win full approval from U.S. regulators. The agency based its decision…
Congress must clarify limits of gene-editing technologies
Genome editing of human embryos represents one of the most contentious potential scientific applications today. But what if geneticists could sidestep the controversy by editing sperm and eggs instead? According…
Progressive group highlights Trump, Tillis weakness on insulin price tags
During the first presidential debate of 2020, President Donald Trump touted his efforts to curb skyrocketing drug prices and declared that insulin is now "so cheap, it’s like…
The two months in 1980 that shaped the future of biotech
Tuesday, December 2, marked the fourth, quietest, but not the least important of this string of biotech events. The U.S. Patent and Trademark Office granted U.S. Patent No. 4,237,224, &ldquo…
D.C. voters to weigh in on ‘magic mushroom’ decriminalization after months-long campaign
Initiative 81, also known as the Entheogenic Plant and Fungus Policy Act of 2020, made the ballot after months of wrangling over its legality and a nationwide debate about policing and the…
I’ve Spent Decades Studying How People Build Their Families. Here’s What I’ve Learned Matters Most
For decades people have raised concerns about families that vary from the structure of one mother, one father and biological children and assumed that the children would be harmed in…
He’d Waited Decades to Argue His Innocence
FRANCIS SHEN, executive director of Harvard’s Center for Law, Brain and Behavior, said the issue of cognitive decline among judges is both considerable and complicated. To take the…
Homemade COVID-19 Vaccine: Does it Work and is it Safe?
An effective COVID-19 vaccine is a concern of most people all over the world, and now, some wonder if having it homemade is the way to go. In fact, 'How…
Trump’s Last-Minute Push For Legally Tenuous Prescription Drug Cards
In a gambit to boost President Donald Trump’s flagging poll numbers among seniors, the Trump administration is hastily assembling a plan that would put $200 debit cards for prescription…
Health officials scrambling to produce Trump’s ‘last-minute’ drug cards by Election Day
Caught by surprise by President Donald Trump’s promise to deliver drug-discount cards to seniors, health officials are scrambling to get the nearly $8 billion plan done by Election Day,…